Corporate decisions such as mergers, schemes of arrangement, disposals of all or the greater part of a company's assets, and certain amendments to a company's memorandum of incorporation can fundamentally alter the nature and value of a shareholder's investment. 

While the principle of majority rule is central to company law, it is equally important that minority shareholders are afforded meaningful protection when they disagree with transformative corporate actions. The Companies Act 71 of 2008, as amended (the “Act”), does not force shareholders to accept a transaction they consider unfair, nor does it allow them to block a deal the majority supports. 

Instead, section 164 of the Act offers a third option. This appraisal remedy entitles a dissenting shareholder to exit the company on their own terms by requiring the company to buy back their shares at fair value. Section 164 recognises that while shareholders may be outvoted, they should not necessarily be compelled to remain shareholders following a transaction that materially changes the company or their investment. This article unpacks how the appraisal remedy works, what triggers it, who can rely on it and the procedural steps involved.

Let’s set the scene: A company's board of directors proposes a merger. The majority of shareholders support it, but one shareholder disagrees with the decision, for whatever plethora of reasons. The question then remains: Does the “minority” shareholder have any option beyond accepting a deal they consider unfair, or launching costly litigation to block it? Section 164 of the Act offers an answer to this question through the appraisal remedy. Rather than allowing a dissenting shareholder to frustrate a transaction that the majority supports, section 164 of the Act gives that shareholder a different kind of exit mechanism, being the right to require the company to buy back its shares for fair value. The appraisal remedy represents a careful balance between the principle of majority rule and the protection of minority shareholder interests. It provides shareholders with an exit mechanism that seeks to ensure they receive fair compensation for their investment, while allowing companies to proceed with transactions that have been validly approved by the requisite majority.

What is the appraisal remedy?
Company decisions are, as a rule, made by majority vote, and a company should not be held hostage by a single dissenting shareholder. At the same time, some transactions are significant enough (such as altering share rights, merging the company with another, or disposing of substantially all its assets) that a shareholder who never agreed to the transaction should not simply be forced to remain invested on the majority's terms. 

Section 164 resolves this tension by allowing the transaction to proceed, while giving the dissenting shareholder a right to exit, not at the price offered to shareholders generally, but at the "fair value" of their shares, determined independently of the transaction that triggered the dispute. Interestingly, the company, not a third party, is obliged to make that payment. Importantly, the fair value paid to a dissenting shareholder is not necessarily the same as the market price of the shares, nor the price offered in the underlying transaction. It is assessed on its own terms, which is often the most contested part of the process. 

When does the appraisal remedy apply?
Unlike a claim based on oppression or unfair prejudice under section 163, appraisal rights do not require the shareholder to prove misconduct, bad faith or unfair conduct by the company or its directors. Instead, the remedy is triggered by specific categories of fundamental corporate transactions. Every disagreement between a shareholder and the board does not trigger the appraisal rights. Section 164 applies to a defined set of "fundamental transactions" and related decisions, including:

• A disposal of all or the greater part of the company’s assets. 
• A proposed amalgamation or merger. 
• A proposed scheme of arrangement. 
• Certain amendments to the company's memorandum of incorporation that alter the preferences, rights, limitations or other terms of a class of shares in a manner materially adverse to that class. 
  

Outside of the abovementioned categories, a shareholder who disagrees with a board or shareholder decision generally has no appraisal right. This mechanism in the Act is designed to compensate shareholders who elect not to participate in those transactions. The rationale is straightforward: Where a transaction fundamentally changes the nature of a shareholder's investment, dissenting shareholders should have the opportunity to exit the company on fair terms.

Who may exercise appraisal rights, and how?
Not every dissatisfied shareholder qualifies. To preserve the right, a shareholder generally needs to:

• Have voted against the resolution giving rise to the fundamental transaction. A mere abstention does not suffice ; and
• Comply strictly with the notice and demand periods set out in section 164.

The procedural chronology typically runs as follows:
1. Notice of the meeting. Shareholders must be notified of the meeting and, importantly, of their appraisal rights under section 164. If the company fails to do this, the shareholder is relieved of some of the usual procedural requirements. 
2. Voting against the resolution. At any time before the resolution is voted on, the dissenting shareholder must give the company a written notice expressly objecting to it. The shareholder must then also vote against the resolution when it is put to the meeting. 
3. Written notice of objection and demand. Once the resolution is approved, the company must inform dissenting shareholders within ten business days. The shareholder then has a defined window to demand payment of fair value for their shares. 
4. The company's offer. The company must subsequently offer to pay what its board of directors considers fair value. 
5. Negotiation or court determination. If the shareholder does not accept the company's offer (or if the company fails to make an offer at all), the dissenting shareholder may apply to court for a determination of fair value, together with an order that the company pay it. 

How is "fair value" determined?
One of the most frequently contested aspects of section 164 is the determination of "fair value". The Act, perhaps deliberately, does not prescribe a single valuation methodology, allowing the valuation to be determined on the particular facts of each case.

• Timing matters. Fair value is assessed as at the date on which, and immediately before, the company adopted the resolution giving rise to the appraisal right. 
• Market value is not necessarily fair value. Depending on the circumstances, relevant considerations may include the company’s financial position, the value of its assets and/or liabilities, future earning potential, market-based valuation or other specific factors.
• Courts may call on expert assistance. Where agreement cannot be reached, the court may determine the fair value and make any ancillary orders it considers appropriate. 

The appraisal remedy plays an important role in balancing the practical need for companies to implement transactions supported by their shareholders with the legitimate interests of those who disagree. Whether acting for a company structuring a fundamental transaction or for a shareholder considering whether to dissent, the procedural and valuation questions raised by section 164 are genuinely technical, and the statutory timelines leave little room for error. While majority rule remains essential to corporate governance, the appraisal remedy ensures that dissenting shareholders are not compelled to remain invested in transactions that fundamentally alter the character or value of their investment. Should you require in-depth advice and guidance on the practical aspects of relying on the mechanisms in section 164 of the Act, feel free to contact our team of specialists. 

Disclaimer: This article is the personal opinion/view of the author(s) and does not necessarily present the views of the firm. The content is provided for information only and should not be seen as an exact or complete exposition of the law. Accordingly, no reliance should be placed on the content for any reason whatsoever, and no action should be taken on the basis thereof unless its application and accuracy have been confirmed by a legal advisor. The firm and author(s) cannot be held liable for any prejudice or damage resulting from action taken based on this content without further written confirmation by the author(s).